Related Experiment Video
Updated: Mar 21, 2026
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Hypertension and the Brain: A Risk Factor for More Than Heart Disease
1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Insights
Hypertension significantly contributes to cerebral small vessel disease (cSVD) and cognitive impairment. Understanding these mechanisms is crucial for developing effective treatments to prevent and reverse hypertension-related neurodegeneration.
Area of Science:
- Neurology
- Vascular Biology
- Gerontology
Background:
- Cerebral small vessel disease (cSVD) is a primary cause of cognitive impairment, characterized by arteriopathy affecting cerebrovascular function and cerebral blood flow (CBF).
- Hypertension is a major modifiable risk factor for cSVD, leading to microbleedings, lacunar infarctions, and white matter lesions, all associated with cognitive decline.
- Both high and low blood pressure (BP) are linked to cognitive decline, sparking debate on BP control strategies for optimal brain perfusion and prevention of cSVD and vascular cognitive impairment (VCI).
Purpose of the Study:
- To review current knowledge on cSVD pathogenesis and its connection to hypertension-induced cerebrovascular complications.
- To identify knowledge gaps and stimulate research into specific therapeutic targets for preventing and reversing hypertension-mediated cognitive decline.
- To explore strategies for decelerating neurodegeneration in patients with hypertension-related cerebrovascular diseases.
Main Methods:
- Literature review of studies on cSVD, hypertension, and cognitive impairment.
- Analysis of mechanisms linking hypertension to cerebrovascular damage.
- Synthesis of findings from randomized controlled trials on antihypertensive therapy and cognitive performance.
Main Results:
- Conflicting results from recent trials on antihypertensive therapy's impact on cognitive performance highlight the complexity of BP management in cSVD.
- Hypertension significantly impacts cerebrovascular function, contributing to conditions like cSVD and VCI.
- The review identifies critical knowledge gaps in understanding hypertension's role in neurodegeneration.
Conclusions:
- Further research is needed to elucidate the precise mechanisms of hypertension-induced cerebrovascular damage.
- Identifying specific therapeutic targets is essential to prevent treatment failures and slow neurodegeneration in cSVD patients.
- Understanding the dual role of BP (high and low) in cognitive decline is critical for developing effective therapeutic strategies.
Background:
Cerebral small vessel disease (cSVD), a common risk factor for cognitive impairment, involves unspecific arteriopathy characterized by hypertrophy and endothelial dysfunction that alter cerebrovascular function and auto-regulation of cerebral blood flow (CBF). Microbleedings, subcortical lacunar infarctions and diffuse areas of white matter lesions resulting from vascular injury are associated with reduced cognitive function mostly characterized by difficulties in learning and retention, attention deficits, gait disorders or depression. In recent years, it has become evident that vascular risk factors contribute to the development of cSVD and associated vascular cognitive impairment (VCI). Among them, hypertension emerged as such a major modifiable risk factor since the brain presents an early target for organ damage due to changes in blood pressure (BP). Subsequently both high and, especially in the elderly, low BP have been linked to cognitive decline, which initiated controversial discussions about BP control as a potential therapeutic strategy to achieve optimal brain perfusion and thus, reduce the occurrence of cSVD and cognitive dysfunction. Yet, recent randomized controlled trials examined the impact of anti-hypertensive therapy on cognitive performance with conflicting results.
Summary:
In light of the current knowledge, it becomes apparent that there is an urgent need to understand the mechanisms underlying hypertension-induced cerebrovascular complications in order to identify effective therapeutic targets to prevent and most importantly also reverse cognitive decline mediated through hypertension.
Key Message:
This review summarizes the current knowledge of cSVD pathogenesis as well as possible links to hypertension-mediated cerebrovascular complications. By pointing out knowledge gaps, it aims to spur future studies in search of specific targets helping to prevent therapy failures and decelerate the rapidly progressing neuro-degeneration of patients suffering from cerebrovascular diseases emanating from hypertension.
More Related Videos
Related Concept Videos
01:18Hypertension and Regulation of Blood Pressure
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
01:29Hypertension II: Pathophysiology
01:18Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
01:28Hypertension I: Introduction
01:18Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...